153 related articles for article (PubMed ID: 12176471)
21. Basiliximab with delayed introduction of calcineurin inhibitors as a renal-sparing protocol following liver transplantation in children with renal impairment.
Mouzaki M; Yap J; Avinashi V; Babu A; Fu A; Deangelis M; Van Roestel K; Ghanekar A; Kamath B; Avitzur Y; Fecteau A; Jones N; Ling S; Grant D; Ng V
Pediatr Transplant; 2013 Dec; 17(8):751-6. PubMed ID: 24118898
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of basiliximab in pediatric renal transplantation.
García-Meseguer C; Roldán M; Melgosa M; Alonso A; Peña A; Espìnosa L; Navarro M
Transplant Proc; 2002 Feb; 34(1):102-3. PubMed ID: 11959206
[No Abstract] [Full Text] [Related]
24. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
Lee H; Lee S; Jeon JS; Kwon SH; Noh H; Han DC; Yun S; Song D
Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348
[TBL] [Abstract][Full Text] [Related]
25. Use of basiliximab in pediatric liver transplantation for Langerhans cell histiocytosis.
Rajwal SR; Stringer MD; Davison SM; Gerrard M; Glaser A; Tanner MS; McClean P
Pediatr Transplant; 2003 Jun; 7(3):247-51. PubMed ID: 12756053
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea.
Baek CH; Kim JH; Yu H; Shin E; Cho H; Kim H; Yang WS; Han DJ; Park SK
Exp Clin Transplant; 2016 Aug; 14(4):389-93. PubMed ID: 27228054
[TBL] [Abstract][Full Text] [Related]
27. Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients.
Sifontis NM; Benedetti E; Vasquez EM
Transplant Proc; 2002 Aug; 34(5):1730-2. PubMed ID: 12176554
[No Abstract] [Full Text] [Related]
28. Effect of immunosuppressive regimen on acute rejection and liver graft function.
Ziolkowski J; Paczek L; Niewczas M; Senatorski G; Oldakowska-Jedynak U; Wyzgal J; Foroncewicz B; Mucha K; Zegarska J; Nyckowski P; Zieniewicz K; Patkowski W; Krawczyk M; Ziarkiewicz-Wroblewska B; Gornicka B
Transplant Proc; 2003 Sep; 35(6):2281-3. PubMed ID: 14529915
[TBL] [Abstract][Full Text] [Related]
29. Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
Martinez-Mier G; Soto-Miranda E; Avila-Pardo SF; Budar-Fernandez LF; Mateu-Rivera LJ; Mendez-Lopez MT; Trujillo-Martinez MF; Uscanga-Montesano A; Avila Y Falfan D
Transplant Proc; 2016 Mar; 48(2):600-4. PubMed ID: 27110011
[TBL] [Abstract][Full Text] [Related]
30. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.
Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A
Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926
[TBL] [Abstract][Full Text] [Related]
31. The role of basiliximab induction therapy in adult-to-adult living-related transplantation and deceased donor liver transplantation: a comparative retrospective analysis of a single-center series.
Viganò J; Gruttadauria S; Mandalà L; Petridis I; Cintorino D; Li Petri S; Varotti G; Minervini M; Volpes R; Biondo D; Vizzini G; Marsh WJ; Marcos A; Gridelli B
Transplant Proc; 2008; 40(6):1953-5. PubMed ID: 18675099
[TBL] [Abstract][Full Text] [Related]
32. Preventing acute rejection with basiliximab and triple immunosuppression after renal transplantation.
Kandus A
Transplant Proc; 2002 Nov; 34(7):2907-9. PubMed ID: 12431653
[No Abstract] [Full Text] [Related]
33. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.
Vítko S; Klinger M; Salmela K; Wlodarczyk Z; Tydèn G; Senatorski G; Ostrowski M; Fauchald P; Kokot F; Stefoni S; Perner F; Claesson K; Castagneto M; Heemann U; Carmellini M; Squifflet JP; Weber M; Segoloni G; Bäckman L; Sperschneider H; Krämer BK
Transplantation; 2005 Dec; 80(12):1734-41. PubMed ID: 16378069
[TBL] [Abstract][Full Text] [Related]
34. Delayed tacrolimus is safe with basiliximab induction therapy.
Lee KH; Da Costa M; Lim SG; Tan KC
Liver Transpl; 2002 Aug; 8(8):732. PubMed ID: 12149770
[No Abstract] [Full Text] [Related]
35. Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.
Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
Transplant Proc; 2006 Dec; 38(10):3633-5. PubMed ID: 17175352
[TBL] [Abstract][Full Text] [Related]
36. Treatment of steroid-resistant acute liver transplant rejection with basiliximab.
Fernandes ML; Lee YM; Sutedja D; Wai CT; Isacc J; Prabhakaran K; Lim SG; Lee KH
Transplant Proc; 2005 Jun; 37(5):2179-80. PubMed ID: 15964372
[TBL] [Abstract][Full Text] [Related]
37. Initial data on basiliximab in critically ill children undergoing heart transplantation.
Ford KA; Cale CM; Rees PG; Elliott MJ; Burch M
J Heart Lung Transplant; 2005 Sep; 24(9):1284-8. PubMed ID: 16143246
[TBL] [Abstract][Full Text] [Related]
38. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Alvarez Castro AM; Seijo Ríos S; Molina Pérez E; Castroagudín JF; Varo Pérez E
Gastroenterol Hepatol; 2012 Nov; 35(9):649-51. PubMed ID: 22749511
[TBL] [Abstract][Full Text] [Related]
39. Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy.
Venzke A; Ganschow R; Grabhorn E; Rogiers X; Burdelski M
Pediatr Transplant; 2003 Oct; 7(5):404-7. PubMed ID: 14738304
[TBL] [Abstract][Full Text] [Related]
40. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.
Welberry Smith MP; Cherukuri A; Newstead CG; Lewington AJ; Ahmad N; Menon K; Pollard SG; Prasad P; Tibble S; Giddings E; Baker RJ
Transplantation; 2013 Dec; 96(12):1082-8. PubMed ID: 24056618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
